Revvity | PKI - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Agilent USD 1.44B 9M 2026-03
Align Technology USD 862.03M 39.18M 2026-03
Bio Techne USD 235.92M 5.5M 2026-03
Bio-Rad Laboratories USD 6.85B 6.21B 2026-03
Bruker USD 813.2M 87.7M 2026-03
Celltrion KRW 140.68B 584.31B 2025-12
Charles River Laboratories USD 875.93M 42.48M 2026-03
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Danaher USD 52.95B 47.61B 2026-03
Dentsply International USD 1.32B 895M 2026-03
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Divis Laboratories Ltd INR 20.17B 1.85B 2026-03
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Illumina USD 852M 51M 2026-03
Intuitive Surgical USD 1.91B 89.8M 2026-03
IQVIA Holdings USD 6.22B 4.53B 2026-03
Kangmei Pharma CNY 1.09B 304.02M 2026-03
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Laboratory Of America USD 3.13B 6.3M 2026-03
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Mesa Laboratories USD 33.98M 2.03M 2024-12
Mettler Toledo International USD 713.2M 64.61M 2026-03
Myriad Genetics USD 212.8M 16.2M 2025-12
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Organigram Holdings CAD 83.66M 24.44M 2025-12
Ovoca Bio EUR 1.16M 4.48M 2025-06
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Pharma Mar EUR 42.28M 4.59M 2026-03
Qiagen NV USD 418.54M 23.25M 2025-12
Quest Diagnostics USD 2.5B 76M 2026-03
Quidel USD 1.85B 1.09B 2026-03
Repligen USD 174.27M 3.67M 2026-03
Revvity USD 628.34M 2.12M 2026-03
Sartorius EUR 738.4M 22.4M 2026-03
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Tilray USD 237.52M 17.34M 2025-09
Waters USD 1.12B 457.15M 2026-03
Zealand Pharma A/S 775.97M 265.08M 2025-12
Zz Pientze Pharmaceu CNY 1.88B 326.34M 2026-03